0001209191-23-004146.txt : 20230119 0001209191-23-004146.hdr.sgml : 20230119 20230119214721 ACCESSION NUMBER: 0001209191-23-004146 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230117 FILED AS OF DATE: 20230119 DATE AS OF CHANGE: 20230119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Melemed Allen S. CENTRAL INDEX KEY: 0001815774 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35867 FILM NUMBER: 23538783 MAIL ADDRESS: STREET 1: C/O CHIMERIX, INC. STREET 2: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHIMERIX INC CENTRAL INDEX KEY: 0001117480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330903395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919.806.1074 MAIL ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-17 0 0001117480 CHIMERIX INC CMRX 0001815774 Melemed Allen S. C/O CHIMERIX, INC. 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 0 1 0 0 Chief Medical Officer Common Stock 2023-01-17 4 A 0 25740 0.00 A 47887 D Stock Option (Right to Buy) 1.97 2023-01-17 4 A 0 154260 0.00 A 2033-01-16 Common Stock 154260 154260 D The shares being reported are being issued pursuant to restricted stock unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 6,435 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 6,435 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 6,435 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 6,435 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant. Includes 4,345 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on March 10, 2021, 6,414 shares acquired under the ESPP on September 10, 2021, 6,707 shares acquired under the ESPP on March 10, 2022 and 4,681 shares acquired under the ESPP on September 9, 2022. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant. /s/ Michael Alrutz, Attorney-in-Fact 2023-01-19